APPLICATIONS PUBLISHED 13 APRIL 2005

Compsns having enhanced deposition of a topically active compound on a surface
The Dial Corp 1521569*

Oral dosage form comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic compsn
Alza Corp 1521570*

Solid dispersion comprising two different polymer matrices
Janssen Pharmaceutica 1521571*

Bioerodible film for ophthalmic drug delivery
Alcon 1521572*

Non-polymeric lipophilic pharmaceutical implant compsns for intraocular use
Alcon 1521573*

Solid pharmaceutical compsn containing a lipophilic active principle and preparation method thereof
CLL Pharma 1521574*

Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds
Centre National de la Recherche Scientifique 1521575*

Novel pharmaceutical compsns comprising novel anticholinergic agents and PDE-IV inhibitors
Boehringer Ingelheim Pharma 1521576*

Methods of treating isothiazole derivatives to treat cancer or inflammation
QLT 1521577*

A novel use of rapamycin and structural analogues thereof
Universita" Degli Studi di Ferrara; Associazione Veneta per le Lotta alla Talassemia 1521578*

Novel medicament combinations based on sodium channel blockers and magnesium salts
Boehringer Ingelheim Pharma 1521579*

Novel pharmaceutical compsns comprising novel anticholinergic agents and NK1-receptor antagonists
Boehringer Ingelheim Pharma 1521580*

Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocardiatis
UCB Farchim 1521581*

2,5-substituted pyrimidine derivatives as CCR-3 receptor antagonists
F Hoffman-La Roche 1521582*

7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo (2,1-B)-quiazolinone derivatives
Actelion Pharmaceuticals 1521583*

Purine derivatives as liver X receptor agonists
Glaxo Group 1521584*

Immunostimulation by chemically modified RNA
Curevac 1521585*

Use of a chrysanthellum extract
Laboratoire Sicobel 1521586*

GP41 peptides and methods based thereon for inhibiting HIV fusion to target cells
Mymetics Corp 1521587*

Use of alanyl-aminopeptidase inhibitors and pharmaceutical compsns containing said inhibitors
Institut fuer Medizintechnologie Magdeburg 1521588*

Bioactivation of particles
Regents of the University of California 1521589*

Novel medicament combinations based on magnesium salts and fibrinolytics
Boehringer Ingelheim Pharma 1521590*

Use of PTHRP antagonists for treating renal cell carcinoma
Universite Louis Pasteur; Institut National de la Sante et de la Recherche Medicale 1521591*

Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis in cattle
Pfizer Products 1521592*

Transdermal botulinium toxin compsns
Allergan 1521593*

Endogenous retrovirus polypeptides linked to oncogenic transformation
Chiron 1521594*

Novel drug compsn based on novel anticholinergics and inhibitors of EGFR-kinase
Boehringer Ingelheim Pharma 1521595*

Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine
Sandoz 1521596*

Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol
Sandoz 1521597*

Adjuvant containing xenon
Air Liquide Deutschland 1521598*

Absorption enhancing agent
Lyfjathroun 1521599*

Bisacyloxypropylcysteine conjugates and the use thereof
GBF-Gesellschaft fuer Biotechnologische Forschung 1521600*

Water-absorbing, foam-type polymer structures
Stockhausen 1521601*

Resorbable structure for treating and healing of tissue defects
Kensey Nash Corp 1521602*

Dru powder inhaler for use with piezoelectric polymer-driven delivery means, and associated blister package comprising a piezoelectric polymer material
Oriel Therapeutics 1521609*

Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
AstraZeneca 1521742*

HMG-CoA reductase inhibitors
Ranbaxy Laboratories 1521743*

Arylsulphonamide derivatives and use thereof as B1 bradykinin receptor antagonists
Laboratoires Fournier 1521744*

Method of producing imidazolium salts
Studiengesellschaft Kohle 1521745*

Quinazolineone modulators of nuclear receptors
X-Ceptor Therapeutics 1521746*

Receptor-type kinase modulators and methods of use
Exelixis 1521747*

Novel anthracene derivatives and the use thereof as a medicament
Zentaris 1521748*

Phenyl-(4-(3-phenyl-1H-[yrazol-4-yl)-pyridinium-2-yl)-amine derivatives
Novartis 1521749*

Novel macrocycles for the treatment of cancer diseases
Gesellschaft fuer Biotechnologische Forschung 1521750*

Substituted 3-cyanoquinolines as MEK inhibitors
AstraZeneca 1521751*

Novel macrocycles for the treatment of cancer
Gesellschaft fuer Biotechnologische Forschung 1521752*

A process to prepare pioglitazone via several intermediates
Cadila Healthcare 1521753*

Viral inhibitors
KU Leuven Research & Development; Gilead Sciences; Puerstinger, Gerhard 1521754*

Novel diketopyrrolopyrrole pigments
Clariant 1521755*

Hetero-cyclically substituted imidalotriazines
Bayer HealthCare 1521756*

Novel tricyclic spiropiperidines or spiropyrrolidines
AstraZeneca 1521757*

N-acetyl-d-glucosamine and process for producing N-acetyl-D-glucosamine
Cargill 1521760*

Treatment of congenital disorders of glycosylation (CDG) using mannose
Marquand, Thorsten; SHS Gesellschaft fuer Klinische Ernaehrung 1521761*

Process for the production of aminoalkyl glucosamine phosphate and disaccharides
Corixa Corp 1521762*

Novel nonsteroidal anti-inflammatory substances, compsns and methods for their use
Pliva-Istrazivacki Institut 1521763*

New compounds, compsns and methods for treatment of inflammatory diseases and conditions
Pliva-Istrazivacki Institut 1521764*

Bafilomycon-like metabolite from a novel micromonospora species
Janssen Pharmaceutica 1521765*

Sliceosome mediated RNA trans-splicing and correction of factor VIII genetic defects using spliceosome mediated RNA trans-splicing
Intronn 1521766*

Methods and constructs for high yield expression of clostripain
Restorogen 1521767*

RNA interference mediated inhibition of vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (SINA)
Sima Therapeutics 1521768*

Tubulysin conjugates
Doemling, Alexander 1521769*

Method for the production of protamine
Tadros, Monier 1521770*

Streptococcus pneumoniae PBP2X mini-protein and uses thereof
Commisariat a l"Energie Atomique; Centre National de la Recherche Scientifique 1521771*

Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans and animals suffering from conformational diseases
Eidgenoessische Technische Hochschule Zuerich 1521772*

Phosphoinpsitolglycan (PIG)-binding protein for adipocytes
Aventis Pharma Deutschland 1521773*

Truncated tau proteins
Axon Neuroscience Forschungs- und Entwicklungs 1521774*

Monoclonal antibody PAM4 and its use for diagnosis and therapy of pancreatic cancer
Immunomedics 1521775*

Neoplasm specific antibodies and uses thereof
Oncomab 1521776*

Depolymerisation o water soluble polysaccharides
Akzo Nobel 1521777*

O-sulphated bacterial polysaccharides and their uses
Inalco 1521778*

Compounds that bind to interferon-gamma, preparation method thereof and medicaments containing same
Commissariat a l"Energie Atomique; Centre National de la Recherche Scientifique 1521779*

Method for obtaining modified polysaccharides by oxidation of hydroxyl groups
Centre National de la Recherche Scientifique 1521780*

Preparation of functionalised anionic polymerisation initiators
Bridgestone 1521781*

Preparation of catalyst systems
Basell Polyolefine 1521782*